Gilead Sciences, Inc. Financials

Market Capitalization $138.71 Billion as of July 1, 2025

Valuations Metrics as of Jul. 4, 2025

Trailing PE	23.43
Forward PE	15.01
Price to Sales TTM	$4.83
Price to Book MRQ	$7.25
Enterprise to Revenue	5.36
Enterprise to EBITDA	11.23

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends	2024-12-31
Most Recent Quarter	2025-03-31
Profit Margin	20.76%
Operating Margin	38.49%
Return on Assets TTM	12.14%
Return on Equity TTM	32.65%

Income Statement

Revenue TTM	$28,735,000,576
Revenue per Share TTM	$23.05
Quarterly Revenue Growth	-0.30%
Gross Profit TTM	$22,496,000,000
EBITDA	$13,411,000,000
Net Income to Common TTM	$5,965,000,192
Diluted EPS TTM	$4.76
Quarterly Earnings Growth YoY	-0.28%

Balance Sheet

Total Cash MRQ	$8,711,000,064
Total Cash per Share MRQ	$7.00
Total Debt MRQ	$
Total Debt to Equity MRQ	130.79
Current Ratio MRQ	1.37
Book Value per Share MRQ	$15.39

Cash Flow

Operating Cash Flow TTM	$10,366,000,128
Levered Free Cash Flow TTM	$9,989,000,192

GILD Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding	1,246,265,857
Float Shares	1,241,354,188
Avg 10 Volume	10,443,000
Avg 30 Volume	None
Shares Short	22,993,007
Short Ratio	2.85
Short % of Shares	1.85%
% Held by Insiders	0.10%
% Held by Institutions	89.60%

Stock Price Summary

Beta	0.31
Fifty Two Week Low	$66.01
Fifty Two Week High	$119.96
Fifty Two Week Change	40.32%
Day 50 MA	$106.53
Day 200 MA	$98.74

Dividends and Splits

Forward Annual Dividend Rate	$3.16
Forward Annual Dividend Yield	2.83%
Trailing Annual Dividend Rate	$3.12
Trailing Annual Dividend Yield	2.79%
Payout Ratio	65.13%
Dividend Date	2025-06-27
Ex Dividend Date	2025-06-13
Last Split Factor
Last Split Date	2013-01-28